Pasithea Therapeutics Corp. (KTTA)
0.5801
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.5801
0.00 (0.00%)
After-Hours: 20:00
Pasithea Therapeutics EPS Diluted (Quarterly) : -0.1643 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1643 |
| March 31, 2026 | -0.1179 |
| December 31, 2025 | -0.8895 |
| September 30, 2025 | -0.4081 |
| June 30, 2025 | -0.6587 |
| March 31, 2025 | -1.611 |
| December 31, 2024 | -2.404 |
| September 30, 2024 | -2.873 |
| June 30, 2024 | -3.706 |
| March 31, 2024 | -3.704 |
| December 31, 2023 | -4.847 |
| September 30, 2023 | -2.872 |
| Date | Value |
|---|---|
| June 30, 2023 | -2.881 |
| March 31, 2023 | -2.714 |
| December 31, 2022 | -3.931 |
| September 30, 2022 | -3.455 |
| June 30, 2022 | -2.268 |
| March 31, 2022 | -1.368 |
| December 31, 2021 | 0.5478 |
| September 30, 2021 | -2.311 |
| June 30, 2021 | -1.057 |
| March 31, 2021 | -0.7978 |
| September 30, 2020 | -0.0212 |
| June 30, 2020 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.274M |
| Total Expenses (Quarterly) | 5.274M |
| Enterprise Value | -26.37M |
| Earnings Yield | -272.3% |
| Normalized Earnings Yield | -276.38 |